Disrupting Aging
Disrupting Aging
At the Spring 2015 Gladstone President's Council Symposium, Disrupting Aging, experts across all three institutes described how aging relates to their research.
AgingGladstone NOW: The Campaign Join Us on the Journey ✕
1246 - 1260 of 1429 Results Clear All
At the Spring 2015 Gladstone President's Council Symposium, Disrupting Aging, experts across all three institutes described how aging relates to their research.
AgingThe initiative will fast-track new approaches to treat Alzheimer’s disease.
News Release Alzheimer’s DiseaseThe new system could serve as a drug-screening tool to make pregnancies safer.
Conklin Lab Stem Cells/iPSCsThe discovery of cell reprogramming by Shinya Yamanaka changed the way scientists see cell biology, but the details of how it works are still being defined. In a recent paper, the labs of Yamanaka and Bruce Conklin show how one key factor—NANOG—is involved in the process.
Conklin Lab Yamanaka Lab Stem Cells/iPSCsCollaborations have been key to Gladstone’s scientific success since its founding, and its community believes that the biggest challenges in science are better met by bringing together researchers with diverse backgrounds.
Bruneau Lab Pollard Lab Srivastava Lab Stem Cells/iPSCsDr. Warner Greene urged graduates to be present, be prepared to reinvent themselves, be a bridge builder, be willing to pay it forward, and be committed to excellence.
Greene LabWith the opening of the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, the Gladstone Institutes has taken a major step forward in accelerating protein research.
Institutional News Mass Spectrometry FacilityThe Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery opened today at the Gladstone Institutes, as part of a collaboration between Thermo Fisher, Gladstone, the University of California, San Francisco (UCSF), and QB3, to accelerate targeted proteomics research using the most advanced mass spectrometry technologies.
Krogan LabBrianna Bibel, an undergraduate student at St. Mary’s College of California, has joined the lab of Dr. Steve Finkbeiner for the summer after receiving a 2015 Donald A. King Summer Research Fellowship from the Huntington’s Disease Society of America (HDSA).
Huntington’s Disease Finkbeiner LabA new paper reported no link between taking Truvada for oral PrEP and experiencing depression.
HIV/AIDS Infectious Disease Grant LabRevelations about a key cellular pathway have important implications for neurodegenerative diseases like ALS and frontotemporal dementia.
Finkbeiner LabThe new strategy is more sustainable and less risky than the current standard therapies.
McDevitt Lab Stem Cells/iPSCsPrime Minister Shinzo Abe spoke about the value of collaboration between the US and Japan—particularly in the fields of science and technology.
Yamanaka LabLi Gan, PhD, has been selected to present the Inge Grundke-Iqbal Lecture for Alzheimer’s Research at the Alzheimer’s Association International Conference (AAIC) in Washington, D.C. in July.
Alzheimer’s DiseaseFinding could have implications for other autoimmune disorders, such as type I diabetes.
Multiple Sclerosis Diabetes